Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Schering Gets Positive European Review For Zevalin In Follicular Lymphoma

This article was originally published in The Pink Sheet Daily

Executive Summary

CTI anticipates second-half filing in the U.S., CEO Bianco tells “The Pink Sheet” DAILY.

You may also be interested in...



Broader Zevalin NHL Label: 18 Times More Use?

New indication sought in sBLA could mean whopper sales, CTI exec says.

Broader Zevalin NHL Label: 18 Times More Use?

New indication sought in sBLA could mean whopper sales, CTI exec says.

Zevalin Phase II Data Lift Cell Therapeutics

Company submits Xyotax for lung cancer in Europe.

Related Content

Topics

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel